Prevention of Arrhythmia Device Infection Trial (PADIT)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.

Also called NCT01613092

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 241 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01613092
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01613092. Randomized; no masking; primary purpose prevention. Start 2011-05 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Arrhythmia Device Infection Trial (PADIT)
Condition
Arrhythmia
Intervention (Drug)
Incremental
Intervention (Drug)
Cefazolin
Lead sponsor
Population Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct01613092
Content hash
497d213f1aee22ede69e633fc415a34166cea79bc28089ed1ccfbf28f3919b80